ES2150004T3 - Procedimiento de estabilizacion de los acidos grasos poliinsaturados y utilizacion de estos productos estabilizados en terapeutica y en cosmetologia. - Google Patents

Procedimiento de estabilizacion de los acidos grasos poliinsaturados y utilizacion de estos productos estabilizados en terapeutica y en cosmetologia.

Info

Publication number
ES2150004T3
ES2150004T3 ES95925889T ES95925889T ES2150004T3 ES 2150004 T3 ES2150004 T3 ES 2150004T3 ES 95925889 T ES95925889 T ES 95925889T ES 95925889 T ES95925889 T ES 95925889T ES 2150004 T3 ES2150004 T3 ES 2150004T3
Authority
ES
Spain
Prior art keywords
fatty acids
cosmetology
therapeutics
stabilization procedure
stabilized products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95925889T
Other languages
English (en)
Inventor
Jean-Robert Grinda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2150004T3 publication Critical patent/ES2150004T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/50—Use of additives, e.g. for stabilisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)

Abstract

LA INVENCION SE REFIERE AL CAMPO DE LA QUIMICA Y PARTICULARMENTE DE LA QUIMICA TERAPEUTICA. SE REFIERE A UN PROCEDIMIENTO DE ESTABILIZACION DE ACIDOS GRASOS NO SATURADOS O DE SUS ESTERES DE ALCOILO INFERIOR, QUE CONSISTE EN MEZCLAR UNA SOLUCION DE ESTE EN UN SOLVENTE INERTE NO HIDROXILADO, CON UNA HIDROXIALCOIL-CELULOSA, Y A CONTINUACION EN DISOLVER TAL PREPARACION PARA HACERLA PERFECTAMENTE PULVERULENTA. ESTA PREPARACION SE DILUYE A CONTINUACION EN UN VEHICULO O EN UN EXCIPIENTE INERTE NO TOXICO FARMACEUTICAMENTE ACEPTABLE PARA LA REALIZACION DE COMPOSICIONES FARMACEUTICAS O CON UN DILUYENTE O UN VEHICULO INERTE PARA LA REALIZACION DE COMPOSICIONES COSMETICAS.
ES95925889T 1994-07-15 1995-07-17 Procedimiento de estabilizacion de los acidos grasos poliinsaturados y utilizacion de estos productos estabilizados en terapeutica y en cosmetologia. Expired - Lifetime ES2150004T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408810A FR2722410B1 (fr) 1994-07-15 1994-07-15 Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique

Publications (1)

Publication Number Publication Date
ES2150004T3 true ES2150004T3 (es) 2000-11-16

Family

ID=9465440

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95925889T Expired - Lifetime ES2150004T3 (es) 1994-07-15 1995-07-17 Procedimiento de estabilizacion de los acidos grasos poliinsaturados y utilizacion de estos productos estabilizados en terapeutica y en cosmetologia.

Country Status (14)

Country Link
US (1) US5914347A (es)
EP (1) EP0796238B1 (es)
JP (1) JPH10508287A (es)
KR (1) KR100388818B1 (es)
AT (1) ATE193006T1 (es)
DE (1) DE69517050T2 (es)
DK (1) DK0796238T3 (es)
ES (1) ES2150004T3 (es)
FR (1) FR2722410B1 (es)
GR (1) GR3033990T3 (es)
MX (1) MX9701771A (es)
NZ (1) NZ289877A (es)
PT (1) PT796238E (es)
WO (1) WO1996002488A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
AU731785B2 (en) * 1996-03-28 2001-04-05 Gist-Brocades B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US10052299B2 (en) * 2009-10-30 2018-08-21 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
WO2012153832A1 (ja) * 2011-05-12 2012-11-15 日本水産株式会社 炎症性疾患用皮膚外用組成物
US11330817B2 (en) 2013-12-04 2022-05-17 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
US10730821B2 (en) 2015-11-23 2020-08-04 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
JP2023514711A (ja) 2020-02-21 2023-04-07 レトロトップ、 インコーポレイテッド 多価不飽和脂肪酸及びその誘導体の同位体修飾方法
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
JPS60258139A (ja) * 1984-06-05 1985-12-20 Nippon Oil & Fats Co Ltd 金属石けんの水分散体
FR2573653B1 (fr) * 1984-11-23 1988-02-26 Pf Medicament Compositions pharmaceutiques antiandrogenes a base d'acides gras
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid

Also Published As

Publication number Publication date
JPH10508287A (ja) 1998-08-18
KR970706230A (ko) 1997-11-03
WO1996002488A1 (fr) 1996-02-01
NZ289877A (en) 1998-05-27
MX9701771A (es) 1997-12-31
EP0796238B1 (fr) 2000-05-17
GR3033990T3 (en) 2000-11-30
DK0796238T3 (da) 2000-10-02
DE69517050T2 (de) 2001-01-18
DE69517050D1 (de) 2000-06-21
KR100388818B1 (ko) 2003-10-17
US5914347A (en) 1999-06-22
PT796238E (pt) 2000-09-29
EP0796238A1 (fr) 1997-09-24
ATE193006T1 (de) 2000-06-15
FR2722410A1 (fr) 1996-01-19
FR2722410B1 (fr) 1996-10-04

Similar Documents

Publication Publication Date Title
ES2150004T3 (es) Procedimiento de estabilizacion de los acidos grasos poliinsaturados y utilizacion de estos productos estabilizados en terapeutica y en cosmetologia.
ES2754727T3 (es) Uso de N-alquil-N-acilglucaminas especiales en productos de limpieza para la piel
ES2105555T3 (es) Emulsion cosmetica o dermatologica aceite en agua que contiene una composicion autoemulsionable.
MX9703556A (es) Composicion para bloquear los rayos solares y para curar heridas.
AR013225A1 (es) Metodos y composiciones contra lineas finas y/o arrugas
MX9207382A (es) Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene.
ES2136100T3 (es) Composicion lipida para productos cosmeticos que contienen trigliceridos de acidos grasos insaturados.
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
ES2052755T3 (es) Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.
MX9701416A (es) Formulaciones de actividad superficial.
AR003939A1 (es) Compuestos de tipo ceramidas, sus usos, procedimiento para su preparacion, composicion para uso cosmetico o dermatologico que los contienen yprocedimiento de tratamiento cosmetico mediante dichos compuestos
ES2176343T3 (es) Composiciones sanadoras de tratamiento de heridas causadas por el acne que contienen un piruvano, un antioxidante y una mezcla de acidos grasos.
ATE244015T1 (de) Formulierungen fuer faktor ix
MX9708150A (es) Composiciones antibacteriales para curar heridas y metodos para preparar y utilizar las mismas.
ES2177652T3 (es) Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
CO4970777A1 (es) Composicion de agentes beneficos que comprenden mezclas de esteres alfa-hidroxilos
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
MY111841A (en) Injectable liposomal pharmaceutical preparations
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
MX9606502A (es) Composiciones antiqueratoliticas y curativas para heridas y metodos para preparar y utilizar las mismas.
NZ307055A (en) Immunostimulating-wound healing compositions and methods for preparing and using same
ES2180164T3 (es) Agentes acuosos para el cuidado de la piel y del cabello.
AR043106A2 (es) Formulaciones farmaceuticas para la administracion oral y topica y formas de dosis farmaceutica
ES2148123T3 (es) Composiciones cosmeticas para la prevencion y terapia de la perdida del cabello.
AR034314A1 (es) Uso de preparaciones cationicas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 796238

Country of ref document: ES